Clinical Trial Update: Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial update of tandem high-dose melphalan with autologous stem cell transplant in multiple myeloma patients aged 60-70, comparing outcomes with and wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: WiSP Wissenschaftlicher Service Pharma GmbH | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED